Bridgewater Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $316K | Sell |
6,738
-1,230
| -15% | -$57.6K | 0.02% | 327 |
|
|
2025
Q1 | $392K | Buy |
+7,968
| New | +$392K | 0.03% | 274 |
|
|
2023
Q2 | – | Sell |
-10,204
| Closed | -$707K | – | 107 |
|
|
2023
Q1 | $707K | Sell |
10,204
-183
| -2% | -$12.7K | 0.15% | 85 |
|
|
2022
Q4 | $747K | Sell |
10,387
-5,816
| -36% | -$418K | 0.18% | 85 |
|
|
2022
Q3 | $1.15M | Buy |
16,203
+5,984
| +59% | +$425K | 0.32% | 63 |
|
|
2022
Q2 | $787K | Sell |
10,219
-4,373
| -30% | -$337K | 0.16% | 97 |
|
|
2022
Q1 | $1.07M | Buy |
14,592
+230
| +2% | +$16.8K | 0.26% | 83 |
|
|
2021
Q4 | $895K | Buy |
14,362
+156
| +1% | +$9.72K | 0.2% | 104 |
|
|
2021
Q3 | $841K | Sell |
14,206
-18,769
| -57% | -$1.11M | 0.23% | 97 |
|
|
2021
Q2 | $2.2M | Buy |
32,975
+10,785
| +49% | +$721K | 0.7% | 37 |
|
|
2021
Q1 | $1.43M | Buy |
+22,190
| New | +$1.43M | 0.73% | 41 |
|